Cargando…

Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice

As part of our ongoing studies on the potential pathophysiological role of serine/threonine phosphatases (PP) in the mammalian heart, we have generated transgenic mice with cardiac muscle cell-specific overexpression of PP2Acα (PP2A) and PP5 (PP5). For further studies we crossbred PP2A and PP5 mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörner, Mara-Francine, Boknik, Peter, Köpp, Friedrich, Buchwalow, Igor B., Neumann, Joachim, Gergs, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431312/
https://www.ncbi.nlm.nih.gov/pubmed/34502355
http://dx.doi.org/10.3390/ijms22179448
_version_ 1783750907154923520
author Dörner, Mara-Francine
Boknik, Peter
Köpp, Friedrich
Buchwalow, Igor B.
Neumann, Joachim
Gergs, Ulrich
author_facet Dörner, Mara-Francine
Boknik, Peter
Köpp, Friedrich
Buchwalow, Igor B.
Neumann, Joachim
Gergs, Ulrich
author_sort Dörner, Mara-Francine
collection PubMed
description As part of our ongoing studies on the potential pathophysiological role of serine/threonine phosphatases (PP) in the mammalian heart, we have generated transgenic mice with cardiac muscle cell-specific overexpression of PP2Acα (PP2A) and PP5 (PP5). For further studies we crossbred PP2A and PP5 mice to obtain PP2AxPP5 double transgenic mice (PP2AxPP5, DT) and compared them with littermate wild-type mice (WT) serving as a control. The mortality of DT mice was greatly enhanced vs. other genotypes. Cardiac fibrosis was noted histologically and mRNA levels of collagen 1α, collagen 3α and fibronectin 1 were augmented in DT. DT and PP2A mice exhibited an increase in relative heart weight. The ejection fraction (EF) was reduced in PP2A and DT but while the EF of PP2A was nearly normalized after β-adrenergic stimulation by isoproterenol, it was almost unchanged in DT. Moreover, left atrial preparations from DT were less sensitive to isoproterenol treatment both under normoxic conditions and after hypoxia. In addition, levels of the hypertrophy markers atrial natriuretic peptide and B-type natriuretic peptide as well as the inflammation markers interleukin 6 and nuclear factor kappa B were increased in DT. PP2A enzyme activity was enhanced in PP2A vs. WT but similar to DT. This was accompanied by a reduced phosphorylation state of phospholamban at serine-16. Fittingly, the relaxation times in left atria from DT were prolonged. In summary, cardiac co-overexpression of PP2A and PP5 were detrimental to animal survival and cardiac function, and the mechanism may involve dephosphorylation of important regulatory proteins but also fibrosis and inflammation.
format Online
Article
Text
id pubmed-8431312
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84313122021-09-11 Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice Dörner, Mara-Francine Boknik, Peter Köpp, Friedrich Buchwalow, Igor B. Neumann, Joachim Gergs, Ulrich Int J Mol Sci Article As part of our ongoing studies on the potential pathophysiological role of serine/threonine phosphatases (PP) in the mammalian heart, we have generated transgenic mice with cardiac muscle cell-specific overexpression of PP2Acα (PP2A) and PP5 (PP5). For further studies we crossbred PP2A and PP5 mice to obtain PP2AxPP5 double transgenic mice (PP2AxPP5, DT) and compared them with littermate wild-type mice (WT) serving as a control. The mortality of DT mice was greatly enhanced vs. other genotypes. Cardiac fibrosis was noted histologically and mRNA levels of collagen 1α, collagen 3α and fibronectin 1 were augmented in DT. DT and PP2A mice exhibited an increase in relative heart weight. The ejection fraction (EF) was reduced in PP2A and DT but while the EF of PP2A was nearly normalized after β-adrenergic stimulation by isoproterenol, it was almost unchanged in DT. Moreover, left atrial preparations from DT were less sensitive to isoproterenol treatment both under normoxic conditions and after hypoxia. In addition, levels of the hypertrophy markers atrial natriuretic peptide and B-type natriuretic peptide as well as the inflammation markers interleukin 6 and nuclear factor kappa B were increased in DT. PP2A enzyme activity was enhanced in PP2A vs. WT but similar to DT. This was accompanied by a reduced phosphorylation state of phospholamban at serine-16. Fittingly, the relaxation times in left atria from DT were prolonged. In summary, cardiac co-overexpression of PP2A and PP5 were detrimental to animal survival and cardiac function, and the mechanism may involve dephosphorylation of important regulatory proteins but also fibrosis and inflammation. MDPI 2021-08-31 /pmc/articles/PMC8431312/ /pubmed/34502355 http://dx.doi.org/10.3390/ijms22179448 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dörner, Mara-Francine
Boknik, Peter
Köpp, Friedrich
Buchwalow, Igor B.
Neumann, Joachim
Gergs, Ulrich
Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice
title Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice
title_full Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice
title_fullStr Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice
title_full_unstemmed Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice
title_short Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice
title_sort mechanisms of systolic cardiac dysfunction in pp2a, pp5 and pp2axpp5 double transgenic mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431312/
https://www.ncbi.nlm.nih.gov/pubmed/34502355
http://dx.doi.org/10.3390/ijms22179448
work_keys_str_mv AT dornermarafrancine mechanismsofsystoliccardiacdysfunctioninpp2app5andpp2axpp5doubletransgenicmice
AT boknikpeter mechanismsofsystoliccardiacdysfunctioninpp2app5andpp2axpp5doubletransgenicmice
AT koppfriedrich mechanismsofsystoliccardiacdysfunctioninpp2app5andpp2axpp5doubletransgenicmice
AT buchwalowigorb mechanismsofsystoliccardiacdysfunctioninpp2app5andpp2axpp5doubletransgenicmice
AT neumannjoachim mechanismsofsystoliccardiacdysfunctioninpp2app5andpp2axpp5doubletransgenicmice
AT gergsulrich mechanismsofsystoliccardiacdysfunctioninpp2app5andpp2axpp5doubletransgenicmice